A comprehensive understanding of the mechanisms underpinning MyD88’s actions in breast cancer not only unravels the molecular complexities governing tumor progression but also unveils fresh perspectives and potential targets for shaping breast cancer treatment strategies. This evidence concerns the gene MYD88 and breast cancer.